EE268 Temporal Trends in Adverse Event Costs with Nivolumab + Relatlimab Combination Therapy or Nivolumab Monotherapy for Patients with Unresectable or Metastatic Melanoma

Name: Work Video:
Duration: 3 min 30 s
Viviana García-Horton; Zheng‐Yi Zhou; Andriy Moshyk; Lisa Rosenblatt; Dhiren Patel; Y. Xin; Qingyuan Wang; Dennis Christensen; Jennell Palaia
{'id': 'https://openalex.org/W4380150279', 'doi': 'https://doi.org/10.1016/j.jval.2023.03.569', 'title': 'EE268 Temporal Trends in Adverse Event Costs with Nivolumab + Relatlimab Combination Therapy or Nivolumab Monotherapy for Patients with Unresectable or Metastatic Melanoma', 'display_name': 'EE268 Temporal Trends in Adverse Event Costs with Nivolumab + Relatlimab Combination Therapy or Nivolumab Monotherapy for Patients with Unresectable or Metastatic Melanoma', 'publication_year': 2023, 'publication_date': '2023-06-01', 'ids': {'openalex': 'https://openalex.org/W4380150279', 'doi': 'https://doi.org/10.1016/j.jval.2023.03.569'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1016/j.jval.2023.03.569', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S678965', 'display_name': 'Value in Health', 'issn_l': '1098-3015', 'issn': ['1098-3015', '1524-4733'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': 'publisher-specific-oa', 'license_id': 'https://openalex.org/licenses/publisher-specific-oa', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': 'https://doi.org/10.1016/j.jval.2023.03.569', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5048586699', 'display_name': 'Viviana García-Horton', 'orcid': 'https://orcid.org/0000-0003-0835-800X'}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'V. Garcia-Horton', 'raw_affiliation_strings': ['Analysis Group Inc., New York, NY, USA'], 'affiliations': [{'raw_affiliation_string': 'Analysis Group Inc., New York, NY, USA', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101711094', 'display_name': 'Zheng‐Yi Zhou', 'orcid': 'https://orcid.org/0000-0001-9014-8479'}, 'institutions': [{'id': 'https://openalex.org/I4210154413', 'display_name': 'Institute of Group Analysis', 'ror': 'https://ror.org/05bnh6b29', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I4210154413']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Z.Y. Zhou', 'raw_affiliation_strings': ['Analysis Group Inc., London, UK'], 'affiliations': [{'raw_affiliation_string': 'Analysis Group Inc., London, UK', 'institution_ids': ['https://openalex.org/I4210154413']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5035574764', 'display_name': 'Andriy Moshyk', 'orcid': 'https://orcid.org/0000-0003-4895-7103'}, 'institutions': [{'id': 'https://openalex.org/I4210091812', 'display_name': 'Bristol-Myers Squibb (United States)', 'ror': 'https://ror.org/00gtmwv55', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210091812']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'A. Moshyk', 'raw_affiliation_strings': ['Bristol Myers Squibb, Lawrenceville, NJ, USA'], 'affiliations': [{'raw_affiliation_string': 'Bristol Myers Squibb, Lawrenceville, NJ, USA', 'institution_ids': ['https://openalex.org/I4210091812']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5054707936', 'display_name': 'Lisa Rosenblatt', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210091812', 'display_name': 'Bristol-Myers Squibb (United States)', 'ror': 'https://ror.org/00gtmwv55', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210091812']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'L.C. Rosenblatt', 'raw_affiliation_strings': ['Bristol Myers Squibb, Lawrenceville, NJ, USA'], 'affiliations': [{'raw_affiliation_string': 'Bristol Myers Squibb, Lawrenceville, NJ, USA', 'institution_ids': ['https://openalex.org/I4210091812']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5044001788', 'display_name': 'Dhiren Patel', 'orcid': 'https://orcid.org/0000-0003-4611-0814'}, 'institutions': [{'id': 'https://openalex.org/I4210091812', 'display_name': 'Bristol-Myers Squibb (United States)', 'ror': 'https://ror.org/00gtmwv55', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210091812']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'D. Patel', 'raw_affiliation_strings': ['Bristol Myers Squibb, Lawrenceville, NJ, USA'], 'affiliations': [{'raw_affiliation_string': 'Bristol Myers Squibb, Lawrenceville, NJ, USA', 'institution_ids': ['https://openalex.org/I4210091812']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5018819816', 'display_name': 'Y. Xin', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210154413', 'display_name': 'Institute of Group Analysis', 'ror': 'https://ror.org/05bnh6b29', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I4210154413']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Y. Xin', 'raw_affiliation_strings': ['Analysis Group Inc., London, UK'], 'affiliations': [{'raw_affiliation_string': 'Analysis Group Inc., London, UK', 'institution_ids': ['https://openalex.org/I4210154413']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100450678', 'display_name': 'Qingyuan Wang', 'orcid': 'https://orcid.org/0000-0002-3439-287X'}, 'institutions': [{'id': 'https://openalex.org/I4210154413', 'display_name': 'Institute of Group Analysis', 'ror': 'https://ror.org/05bnh6b29', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I4210154413']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Q. Wang', 'raw_affiliation_strings': ['Analysis Group Inc., London, UK'], 'affiliations': [{'raw_affiliation_string': 'Analysis Group Inc., London, UK', 'institution_ids': ['https://openalex.org/I4210154413']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5034593036', 'display_name': 'Dennis Christensen', 'orcid': 'https://orcid.org/0000-0003-2382-8639'}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'D. Christensen', 'raw_affiliation_strings': ['Analysis Group Inc., New York, NY, USA'], 'affiliations': [{'raw_affiliation_string': 'Analysis Group Inc., New York, NY, USA', 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5039871207', 'display_name': 'Jennell Palaia', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210091812', 'display_name': 'Bristol-Myers Squibb (United States)', 'ror': 'https://ror.org/00gtmwv55', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210091812']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'J. Palaia', 'raw_affiliation_strings': ['Bristol Myers Squibb, Lawrenceville, NJ, USA'], 'affiliations': [{'raw_affiliation_string': 'Bristol Myers Squibb, Lawrenceville, NJ, USA', 'institution_ids': ['https://openalex.org/I4210091812']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 3200, 'currency': 'USD', 'value_usd': 3200, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 67}, 'biblio': {'volume': '26', 'issue': '6', 'first_page': 'S108', 'last_page': 'S108'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11491', 'display_name': 'CAR-T cell therapy research', 'score': 0.9904, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11491', 'display_name': 'CAR-T cell therapy research', 'score': 0.9904, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10158', 'display_name': 'Cancer Immunotherapy and Biomarkers', 'score': 0.9829, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10804', 'display_name': 'Health Systems, Economic Evaluations, Quality of Life', 'score': 0.9781, 'subfield': {'id': 'https://openalex.org/subfields/2002', 'display_name': 'Economics and Econometrics'}, 'field': {'id': 'https://openalex.org/fields/20', 'display_name': 'Economics, Econometrics and Finance'}, 'domain': {'id': 'https://openalex.org/domains/2', 'display_name': 'Social Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/combination-therapy', 'display_name': 'Combination therapy', 'score': 0.59078795}], 'concepts': [{'id': 'https://openalex.org/C2780030458', 'wikidata': 'https://www.wikidata.org/wiki/Q7041828', 'display_name': 'Nivolumab', 'level': 4, 'score': 0.98480946}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.80919063}, {'id': 'https://openalex.org/C2994587330', 'wikidata': 'https://www.wikidata.org/wiki/Q180614', 'display_name': 'Metastatic melanoma', 'level': 3, 'score': 0.7964242}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.76747084}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.6684989}, {'id': 'https://openalex.org/C2776999253', 'wikidata': 'https://www.wikidata.org/wiki/Q1304270', 'display_name': 'Combination therapy', 'level': 2, 'score': 0.59078795}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.53567487}, {'id': 'https://openalex.org/C2777658100', 'wikidata': 'https://www.wikidata.org/wiki/Q180614', 'display_name': 'Melanoma', 'level': 2, 'score': 0.47763506}, {'id': 'https://openalex.org/C2777701055', 'wikidata': 'https://www.wikidata.org/wiki/Q1427096', 'display_name': 'Immunotherapy', 'level': 3, 'score': 0.13851461}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.13565218}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.11291596}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1016/j.jval.2023.03.569', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S678965', 'display_name': 'Value in Health', 'issn_l': '1098-3015', 'issn': ['1098-3015', '1524-4733'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': 'publisher-specific-oa', 'license_id': 'https://openalex.org/licenses/publisher-specific-oa', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1016/j.jval.2023.03.569', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S678965', 'display_name': 'Value in Health', 'issn_l': '1098-3015', 'issn': ['1098-3015', '1524-4733'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': 'publisher-specific-oa', 'license_id': 'https://openalex.org/licenses/publisher-specific-oa', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.55, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W95056088', 'https://openalex.org/W4380150279', 'https://openalex.org/W4206770832', 'https://openalex.org/W3117175111', 'https://openalex.org/W2963333658', 'https://openalex.org/W2888298425', 'https://openalex.org/W2766332458', 'https://openalex.org/W2538461063', 'https://openalex.org/W2270117727', 'https://openalex.org/W2192177751'], 'abstract_inverted_index': None, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4380150279', 'counts_by_year': [], 'updated_date': '2025-01-11T12:31:42.108148', 'created_date': '2023-06-11'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
